Additionally, pathogenic variants in the CHEK2 gene have been associated with CRC risk, estimated to be 5–10%, though heterogeneity may exist based on the type of CHEK2 pathogenic variant [203,204,205,206,207,208]. Here, CHEK2 is linked to colorectal carcinoma.